Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.
暂无分享,去创建一个
[1] K. Kivirikko,et al. Modifications of a specific assay for hydroxyproline in urine. , 1967, Analytical biochemistry.
[2] S. Gonnelli,et al. Comparative effects on bone mineral content of calcium and calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis , 1985 .
[3] H. Gundersen,et al. Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition. , 1984, Metabolic bone disease & related research.
[4] L. Miravet,et al. [HISTOLOGICAL MEASURE OF THE VOLUME AND RESORPTION OF BONE JOINTS]. , 1964, Pathologie et biologie.
[5] S. Cummings,et al. An examination of the association between vertebral deformities, physical disabilities and psychosocial problems. , 1988, Maturitas.
[6] F. Melsen,et al. Reconstruction of the resorptive site in iliac trabecular bone: a kinetic model for bone resorption in 20 normal individuals. , 1984, Metabolic bone disease & related research.
[7] M. Dambacher,et al. Diphosphonate treatment of Paget's disease of bone. A correlated metabolic, calcium kinetic and morphometric study. , 1974, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[8] W. Nelp,et al. Long-term calcitonin therapy in postmenopausal osteoporosis. , 1984, Metabolism: clinical and experimental.
[9] L. Avioli,et al. Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study. , 1988, The Journal of clinical endocrinology and metabolism.
[10] S. Pors Nielsen,et al. Measurement of bone mineral content (BMC) of the lumbar spine, I. Theory and application of a new two-dimensional dual-photon attenuation method. , 1980, Scandinavian journal of clinical and laboratory investigation.
[11] ABSORPTION OF ORAL DIPHOSPHONATE IN NORMAL SUBJECTS , 1986, Clinical endocrinology.
[12] C. Christiansen,et al. Bone mineral content in the forearm measured by photon absorptiometry. Principles and reliability. , 1975, Scandinavian journal of clinical and laboratory investigation.
[13] J. Kanis. TREATMENT OF OSTEOPOROTIC FRACTURE , 1984, The Lancet.
[14] H. Fleisch. Diphosphonates: history and mechanisms of action. , 1981, Metabolic bone disease & related research.
[15] S J Pocock,et al. Interim analyses for randomized clinical trials: the group sequential approach. , 1982, Biometrics.
[16] H. Genant,et al. Assessment of metabolic bone diseases by quantitative computed tomography. , 1985, Clinical orthopaedics and related research.
[17] P. Saville,et al. Etidronate disodium in postmenopausal osteoporosis , 1976, Clinical pharmacology and therapeutics.
[18] A. Hodsman. Effects of cyclical therapy for osteoporosis using an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric study. , 1989, Bone and mineral.